Literature DB >> 16337193

Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines.

Patrizia Luppi1, Julie A Deloia.   

Abstract

The maternal syndrome preeclampsia is characterized by a generalized inflammatory response with activation of circulating leukocytes and altered levels of inflammatory cytokines. We hypothesized that one potential source of inflammatory cytokines during preeclampsia is the circulating maternal monocytes. By using flow cytometry, we found that the spontaneous intracellular synthesis of IL-1beta, IL-6, and IL-8 in monocytes of preeclamptic women was higher than in normal pregnant and non-pregnant women. The highest levels of cytokines were detected in women with the most abnormal laboratory values. When stimulated with lipopolysaccharide (LPS), the percentage of IL-1beta+ monocytes was lower in preeclampsia (72.6% +/- 8.2 SEM) than in normal pregnancy (90.7% +/- 2 SEM) (P = 0.03) and non-pregnant women (92.5% +/- 1.4 SEM) (P = 0.04) suggesting that monocytes from preeclamptic patients cannot be further stimulated. These results indicate that maternal circulating monocytes represent a source of inflammatory cytokines during preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337193     DOI: 10.1016/j.clim.2005.11.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  39 in total

1.  Effect of lipoxin A₄ on IL-1β production of monocytes and its possible mechanism in severe preeclampsia.

Authors:  Jianfang Wang; Yinping Huang; Yanjun Huang; Jie Zhou; Xiaoli Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

Review 2.  Toll-like receptors in pregnancy disorders and placental dysfunction.

Authors:  Joan K Riley; D Michael Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

3.  Association between cytokine profile and transcription factors produced by T-cell subsets in early- and late-onset pre-eclampsia.

Authors:  Vanessa R Ribeiro; Mariana Romao-Veiga; Graziela G Romagnoli; Mariana L Matias; Priscila R Nunes; Vera Therezinha M Borges; Jose C Peracoli; Maria Terezinha S Peracoli
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

Review 4.  Association of microparticles and preeclampsia.

Authors:  Fabiana K Marques; Fernanda M F Campos; Lirlândia P Sousa; Andréa Teixeira-Carvalho; Luci M S Dusse; Karina B Gomes
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

5.  Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women.

Authors:  D Gordin; V Hiilesmaa; J Fagerudd; M Rönnback; C Forsblom; R Kaaja; K Teramo; P-H Groop
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

Review 6.  Placental apoptosis in health and disease.

Authors:  Andrew N Sharp; Alexander E P Heazell; Ian P Crocker; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2010-09       Impact factor: 3.886

7.  Nicotine inhibits cytokine production by placenta cells via NFkappaB: potential role in pregnancy-induced hypertension.

Authors:  Oonagh Dowling; Burton Rochelson; Kathleen Way; Yousef Al-Abed; Christine N Metz
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

8.  Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate.

Authors:  Alaa Amash; Gershon Holcberg; Olga Sapir; Mahmoud Huleihel
Journal:  J Interferon Cytokine Res       Date:  2012-08-21       Impact factor: 2.607

9.  Maternal immune system adaptation to pregnancy--a potential influence on the course of diabetic retinopathy.

Authors:  Snježana Kaštelan; Martina Tomić; Josip Pavan; Slavko Orešković
Journal:  Reprod Biol Endocrinol       Date:  2010-10-21       Impact factor: 5.211

10.  Helicobacter pylori seropositivity and its relationship with serum malondialdehyde and lipid profile in preeclampsia.

Authors:  Hulya Aksoy; Asuman Ozkan; Ferda Aktas; Bunyamin Borekci
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.